Details of treatment for patients in China who died of COVID-19

What The Study Did: This case series describes clinical characteristics of patients who died of coronavirus disease 2019 (COVID-19) in China. Authors: Haibo Qiu, M.D., Ph.D., of Zhongda Hospital, Southeast University in Jiangsu, China, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.5619) Editor’s…

Details

Caring for patients with cancer during the COVID-19 outbreak in Italy

What The Article Says: An essay discusses the challenges associated with caring for patients with cancer during the COVID-19 epidemic in Italy. Authors: Filippo Pietrantonio, M.D., and Marina Chiara Garassino, M.D., of the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, are the authors. To access the embargoed study: Visit our For The Media website at this link…

Details

Mental health consequences of COVID-19, physical distancing

What The Viewpoint Says: The article emphasizes the importance of mitigating the mental health consequences of social distancing in the COVID-19 era. Authors: Sandro Galea, M.D., of the Boston University School of Public Health, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamainternmed.2020.1562) Editor’s Note: Please see…

Details

Free program on conducting scientific research without using laboratory animals

BALTIMORE–From June 22 to 25, students and early-career scientists will gather virtually for a free program of lectures, laboratory tours, interactive sessions, e-poster presentations, and virtual engagement with speakers and attendees on innovative methods to reduce and replace animal tests in toxicology and biomedical science. Originally planned to be hosted at Johns Hopkins University, the…

Details

Suicide mortality and COVID-19

What The Viewpoint Says: Reasons why U.S. suicide rates may rise in tandem with the coronavirus disease 2019 (COVID-19) pandemic are explained in this article that also describes opportunities to expand research and care. Authors: Mark A. Reger, Ph.D., of the VA Puget Sound Health Care System, and  Seattle, Washington; and the University of Washington in…

Details

Working together to combat mental health challenges during COVID-19 pandemic

What The Viewpoint Says: This article offers lessons from Hubei, China, on potential methods to focus on mental health during the coronavirus disease 2019 (COVID-19) pandemic. Authors: Yu-Tao Xiang, M.D., Ph.D., of the University of Macau in the Macao Special Administrative Region, China, is the corresponding author. To access the embargoed study: Visit our For The Media website…

Details

Belgian scientists identify ATP10B as novel risk gene for Parkinson’s disease

Screening DNA of Parkinson’s patients in the Christine Van Broeckhoven laboratory (VIB-UAntwerpen Center for Molecular Neurology) identified a new risk gene for Parkinson’s disease. Mutations in ATP10B resulted in loss of ATP10B protein. The function of the ATP10B gene was revealed by the Peter Vangheluwe lab (KU Leuven, Laboratory of Cellular Transport Systems). They identified…

Details

FDA approves COVID-19 innovations; Ohio State Medical Center to share nationwide

The Food and Drug Administration has approved solutions created by scientists at The Ohio State University Wexner Medical Center that both expand and accelerate COVID-19 testing across Ohio. Health systems worldwide have struggled because of the critical shortage of test kit components, including the swabs used to collect samples and the sterile solution needed to…

Details